Avalo Therapeutics, Inc. (AVTX) is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in the areas of Immunology, Immuno-oncology, and Rare Genetic Diseases.
Cerecor | AEVI Merger Details
Please see the attached to documents for detailed information regarding the Aevi acquisition / merger and or a simple question and answer document
|CERECOR SEC S4 Aevi Acquisition||Download|
|CERECOR Q&A Document||Download|